EcoDrugPlus

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSIPUG00000016276
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor A

Ensembl ID : ENSIPUG00000000864
Gene Symbol: MST1RA
3 Cross references
188 Possible Orthologues:

Macrophage Stimulating 1 Receptor B

Ensembl ID : ENSIPUG00000021073
Gene Symbol: MST1RB
3 Cross references
193 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSIPUG00000006564
Gene Symbol: MMP14A
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSIPUG00000016910
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metalloproteinase 13

Ensembl ID : ENSIPUG00000020837
Gene Symbol: LOC108276914
3 Cross references
289 Possible Orthologues:

Matrix Metalloproteinase 9

Ensembl ID : ENSIPUG00000004630
Gene Symbol: MMP9
2 Cross references
214 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSIPUG00000006655
Gene Symbol: LOC108267723
4 Cross references
195 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSIPUG00000019993
Gene Symbol: LOC108267832
4 Cross references
195 Possible Orthologues:

Matrix Metalloproteinase-9-Like

Ensembl ID : ENSIPUG00000004597
Gene Symbol: LOC108265954
3 Cross references
214 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSIPUG00000022002
Gene Symbol: MTOR
3 Cross references
217 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSIPUG00000007015
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).